Načítá se...
Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age
AIM: The purpose of this study was to evaluate the outcomes of infants diagnosed with retinoblastoma before 6 months of age, including the need for chemoreduction (CRD). In this age group, dosage of CRD was reduced due to its potential for toxicity. METHODS: This is a retrospective review from 2000...
Uloženo v:
| Vydáno v: | Ocul Oncol Pathol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
S. Karger AG
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847682/ https://ncbi.nlm.nih.gov/pubmed/27172253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000370215 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|